145 related articles for article (PubMed ID: 38189855)
1. AMIGO2 is a pivotal therapeutic target related to M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
Chen S; Du W; Feng K; Liu K; Li C; Li S; Yin H
Aging (Albany NY); 2024 Jan; 16(2):1111-1127. PubMed ID: 38189855
[TBL] [Abstract][Full Text] [Related]
2. Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.
Tan S; Tang H; Zhang Z; Wang Y; Li H; Shi W; Ye H; Xie P; Zhou J
Clin Med Insights Oncol; 2024; 18():11795549241239042. PubMed ID: 38510315
[TBL] [Abstract][Full Text] [Related]
3. Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma.
Zhang D; Cui F; Peng L; Wang M; Yang X; Xia C; Li K; Yin H; Zhang Y; Yu Q; Jin Z; Huang H
Aging (Albany NY); 2022 Aug; 14(15):6299-6315. PubMed ID: 35963640
[TBL] [Abstract][Full Text] [Related]
4. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
Fan CS; Chen LL; Hsu TA; Chen CC; Chua KV; Li CP; Huang TS
J Hematol Oncol; 2019 Dec; 12(1):138. PubMed ID: 31847880
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S
Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809
[TBL] [Abstract][Full Text] [Related]
6. Octyl Gallate Induces Pancreatic Ductal Adenocarcinoma Cell Apoptosis and Suppresses Endothelial-Mesenchymal Transition-Promoted M2-Macrophages, HSP90α Secretion, and Tumor Growth.
Chua KV; Fan CS; Chen CC; Chen LL; Hsieh SC; Huang TS
Cells; 2019 Dec; 9(1):. PubMed ID: 31905895
[TBL] [Abstract][Full Text] [Related]
7. The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway.
Ma X; Wu D; Zhou S; Wan F; Liu H; Xu X; Xu X; Zhao Y; Tang M
Oncol Rep; 2016 Jan; 35(1):189-96. PubMed ID: 26531138
[TBL] [Abstract][Full Text] [Related]
8. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma.
Lin J; Liu Y; Liu P; Qi W; Liu J; He X; Liu Q; Liu Z; Yin J; Lin J; Bao H; Lin J
J Exp Clin Cancer Res; 2023 Dec; 42(1):339. PubMed ID: 38098044
[TBL] [Abstract][Full Text] [Related]
9. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW
Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules.
Hu J; Jiang J; Xu B; Li Y; Wang B; He S; Ren X; Shi B; Zhang X; Zheng H; Hua B; Liu R
J Ethnopharmacol; 2024 Mar; 322():117590. PubMed ID: 38113986
[TBL] [Abstract][Full Text] [Related]
11. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages.
Li MX; Wang HY; Yuan CH; Ma ZL; Jiang B; Li L; Zhang L; Xiu DR
Clin Sci (Lond); 2021 Feb; 135(4):629-649. PubMed ID: 33538300
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
13. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression.
Liu Y; Wang X; Zhu Y; Cao Y; Wang L; Li F; Zhang Y; Li Y; Zhang Z; Luo J; Deng X; Peng C; Wei G; Chen H; Shen B
Clin Transl Med; 2022 Feb; 12(2):e654. PubMed ID: 35184402
[TBL] [Abstract][Full Text] [Related]
14. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
15. Tissue-resident CXCR4
Liao Z; Ye L; Li T; Jin X; Lin X; Fei Q; Zhang H; Shi S; Yu X; Jin K; Wu W
Int J Cancer; 2023 Jun; 152(11):2396-2409. PubMed ID: 36757203
[TBL] [Abstract][Full Text] [Related]
16. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma.
Zhang J; Sun H; Liu S; Huang W; Gu J; Zhao Z; Qin H; Luo L; Yang J; Fang Y; Ge J; Ni B; Wang H
Aging (Albany NY); 2020 Nov; 12(22):23217-23232. PubMed ID: 33221741
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143
[TBL] [Abstract][Full Text] [Related]
18. S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine.
Li T; Ren T; Huang C; Li Y; Yang P; Che G; Luo L; Chen Y; Peng S; Lin Y; Zeng L
Biochem Pharmacol; 2021 Jul; 189():114396. PubMed ID: 33359364
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma.
Zhang XP; Chen Q; Liu Q; Wang Y; Wang F; Zhao ZM; Zhao GD; Lau WY; Gao YZ; Liu R
J Cell Mol Med; 2021 Jun; 25(12):5615-5627. PubMed ID: 33942483
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Implications of an Autophagy-related Gene Signature in Pancreatic Ductal Adenocarcinoma.
Liu WS; Feng YX; Li SN; Shao YJ; Wang K
Am J Clin Oncol; 2022 Mar; 45(3):95-104. PubMed ID: 35195559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
